Healthcare AI Acquisition Corp. reported its financial results for the second quarter of 2025, revealing a net loss of $542,059 for the three months ending June 30, 2025, compared to a net income of $145,656 during the same period in 2024. For the first half of 2025, the company recorded a net loss of $616,178, a significant increase from a loss of $321,060 in the prior year. The company's revenue remains non-existent as it has not yet completed a business combination, with its only income derived from interest on investments held in a trust account, which decreased to $25,966 for the quarter from $76,205 a year earlier.
The company's balance sheet as of June 30, 2025, shows total assets of $2,860,464, a decline from $5,659,153 at the end of 2024. This decrease is primarily attributed to the redemption of Class A ordinary shares, which resulted in a significant reduction in cash and investments held in the trust account, dropping from $4,664,536 to $1,865,847. Total liabilities increased to $3,160,800, up from $2,394,321, largely due to a rise in accrued offering costs and a promissory note from a related party.
Strategically, Healthcare AI Acquisition Corp. has been working towards completing a business combination, having entered into an agreement with Leading Group Limited, a digital insurance brokerage firm in China, in August 2024. The company has extended its deadline to finalize this business combination multiple times, with the latest extension allowing until October 14, 2025. However, the company faces challenges, including a working capital deficit of $2,503,403 and limited cash resources, which raise concerns about its ability to sustain operations without additional financing.
Operationally, the company has seen a reduction in its shareholder base, with significant redemptions of Class A shares occurring in connection with its extensions and strategic decisions. As of June 30, 2025, there were 5,390,599 Class A shares outstanding, with 152,511 shares subject to possible redemption. The company has also undergone management changes following the transfer of shares to a new sponsor, which may impact its strategic direction moving forward.
Looking ahead, Healthcare AI Acquisition Corp. acknowledges the uncertainty surrounding its ability to complete a business combination by the extended deadline. The company is actively seeking additional capital through working capital loans and other financing options, but there is no assurance that such funding will be available. The management has expressed substantial doubt about the company's ability to continue as a going concern if a business combination is not consummated by the required date.
About Healthcare AI Acquisition Corp.
Healthcare AI Acquisition Corp. is a Cayman Islands exempted company that operates as a blank check firm, aiming to identify and complete mergers or acquisitions in the healthcare AI sector. It issues Class A and B ordinary shares, warrants, and potential preference shares, with a focus on capital structure flexibility and shareholder rights. The company facilitates initial business combinations through shareholder voting, redemption rights, and structured warrant agreements.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.